157 related articles for article (PubMed ID: 18042584)
21. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
22. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene.
Yuasa M; Masutani C; Eki T; Hanaoka F
Oncogene; 2000 Sep; 19(41):4721-8. PubMed ID: 11032022
[TBL] [Abstract][Full Text] [Related]
23. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
25. Photobiological information obtained from XPA gene-deficient mice.
Horio T; Miyauchi-Hashimoto H; Kuwamoto K; Yamazaki F; Okamoto H
Photochem Photobiol; 2007; 83(1):218-24. PubMed ID: 16836470
[TBL] [Abstract][Full Text] [Related]
26. Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.
Zeng L; Sarasin A; Mezzina M
Cell Biol Toxicol; 1998 Mar; 14(2):105-10. PubMed ID: 9553721
[TBL] [Abstract][Full Text] [Related]
27. The discovery that xeroderma pigmentosum (XP) results from defective nucleotide excision repair.
Friedberg EC
DNA Repair (Amst); 2004 Feb; 3(2):183, 195. PubMed ID: 14706352
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of eight groups of xeroderma pigmentosum by genetic complementation using recombinant adenovirus vectors.
Yamashita T; Okura M; Ishii-Osai Y; Hida T
J Dermatol; 2016 Oct; 43(10):1167-1173. PubMed ID: 26971583
[TBL] [Abstract][Full Text] [Related]
29. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
30. Repairing DNA damage in xeroderma pigmentosum: T4N5 lotion and gene therapy.
Zahid S; Brownell I
J Drugs Dermatol; 2008 Apr; 7(4):405-8. PubMed ID: 18459526
[TBL] [Abstract][Full Text] [Related]
31. [Pigmentary lesions in patients with increased DNA damage due to defective DNA repair].
Krieger L; Berneburg M
Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S78-82. PubMed ID: 23260522
[TBL] [Abstract][Full Text] [Related]
32. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
33. Topical thymidine dinucleotide application protects against UVB-induced skin cancer in mice with DNA repair gene (Ercc1)-deficient skin.
Lawrence NJ; Song L; Doig J; Ritchie AM; Brownstein DG; Melton DW
DNA Repair (Amst); 2009 May; 8(5):664-71. PubMed ID: 19264557
[TBL] [Abstract][Full Text] [Related]
34. Deficient base excision repair of oxidative DNA damage induced by methylene blue plus visible light in xeroderma pigmentosum group C fibroblasts.
Kassam SN; Rainbow AJ
Biochem Biophys Res Commun; 2007 Aug; 359(4):1004-9. PubMed ID: 17573042
[TBL] [Abstract][Full Text] [Related]
35. Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease.
Karass M; Naguib MM; Elawabdeh N; Cundiff CA; Thomason J; Steelman CK; Cone R; Schwenkter A; Jordan C; Shehata BM
Fetal Pediatr Pathol; 2015 Apr; 34(2):120-7. PubMed ID: 25454817
[TBL] [Abstract][Full Text] [Related]
36. Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis.
Kawamoto T; Araki K; Sonoda E; Yamashita YM; Harada K; Kikuchi K; Masutani C; Hanaoka F; Nozaki K; Hashimoto N; Takeda S
Mol Cell; 2005 Dec; 20(5):793-9. PubMed ID: 16337602
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum: beyond skin cancer.
Lichon V; Khachemoune A
J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
[TBL] [Abstract][Full Text] [Related]
38. Bacterial DNA repair genes and their eukaryotic homologues: 4. The role of nucleotide excision DNA repair (NER) system in mammalian cells.
Maddukuri L; Dudzińska D; Tudek B
Acta Biochim Pol; 2007; 54(3):469-82. PubMed ID: 17893751
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases.
Redondo P; Prieto J; Muñoz IG; Alibés A; Stricher F; Serrano L; Cabaniols JP; Daboussi F; Arnould S; Perez C; Duchateau P; Pâques F; Blanco FJ; Montoya G
Nature; 2008 Nov; 456(7218):107-11. PubMed ID: 18987743
[TBL] [Abstract][Full Text] [Related]
40. Validation of XP-C pathogenic variations in archival material from a live XP patient.
McDaniel LD; Rivera-Begeman A; Doughty AT; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):115-20. PubMed ID: 17084680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
